{"date":"2025-09-16","count":11,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6815-2025-09-16-1812-1dom3vj","company_id":"6815","company":"晶鑽生醫","market":"興櫃","industry":"生技醫療","date":"2025-09-16","time":"18:12:28","subject":"公告本公司取得醫療器材品質管理系統準則(QMS)製造許可","clause":"第44款","fact_date":"2025-09-16","cite_as":"公開資訊觀測站重大訊息：晶鑽生醫（6815），2025-09-16 18:12，「公告本公司取得醫療器材品質管理系統準則(QMS)製造許可」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6712-2025-09-16-1750-10jca0t","company_id":"6712","company":"長聖","market":"上櫃","industry":"生技醫療","date":"2025-09-16","time":"17:50:49","subject":"本公司受邀參加凱基證券舉辦之法人說明會","clause":"第12款","fact_date":"2025-09-18","cite_as":"公開資訊觀測站重大訊息：長聖（6712），2025-09-16 17:50，「本公司受邀參加凱基證券舉辦之法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6499-2025-09-16-1746-om8fyo","company_id":"6499","company":"益安","market":"上櫃","industry":"生技醫療","date":"2025-09-16","time":"17:46:24","subject":"代重要子公司意能生技股份有限公司公告董事會訂定現金增資認股基準日等相關事宜","clause":"第11款","fact_date":"2025-09-16","cite_as":"公開資訊觀測站重大訊息：益安（6499），2025-09-16 17:46，「代重要子公司意能生技股份有限公司公告董事會訂定現金增資認股基準日等相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6499-2025-09-16-1737-t60g0b","company_id":"6499","company":"益安","market":"上櫃","industry":"生技醫療","date":"2025-09-16","time":"17:37:53","subject":"代重要子公司意能生技股份有限公司公告114年第二次普通股暨特別股股東臨時會重要決議事宜","clause":"第18款","fact_date":"2025-09-16","cite_as":"公開資訊觀測站重大訊息：益安（6499），2025-09-16 17:37，「代重要子公司意能生技股份有限公司公告114年第二次普通股暨特別股股東臨時會重要決議事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4161-2025-09-16-1617-1ovykzz","company_id":"4161","company":"聿新科","market":"上櫃","industry":"生技醫療","date":"2025-09-16","time":"16:17:23","subject":"公告本公司股票股利發放日延至114年9月30日(現金股利發放日仍為114年9月24日)","clause":"第14款","fact_date":"2025-09-16","cite_as":"公開資訊觀測站重大訊息：聿新科（4161），2025-09-16 16:17，「公告本公司股票股利發放日延至114年9月30日(現金股利發放日仍為114年9月24日)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6926-2025-09-16-1556-10jca0t","company_id":"6926","company":"聖安生醫","market":"興櫃","industry":"生技醫療","date":"2025-09-16","time":"15:56:01","subject":"本公司受邀參加凱基證券舉辦之法人說明會","clause":"第30款","fact_date":"2025-09-18","cite_as":"公開資訊觀測站重大訊息：聖安生醫（6926），2025-09-16 15:56，「本公司受邀參加凱基證券舉辦之法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4168-2025-09-16-1507-s3vmd6","company_id":"4168","company":"醣聯","market":"上櫃","industry":"生技醫療","date":"2025-09-16","time":"15:07:01","subject":"公告本公司發行國內第四次有擔保轉換公司債收足債款","clause":"第53款","fact_date":"2025-09-16","cite_as":"公開資訊觀測站重大訊息：醣聯（4168），2025-09-16 15:07，「公告本公司發行國內第四次有擔保轉換公司債收足債款」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4114-2025-09-16-1438-1ot4w87","company_id":"4114","company":"健喬","market":"上櫃","industry":"生技醫療","date":"2025-09-16","time":"14:38:25","subject":"公告本公司已將本次公開收購健亞生物科技股份有限公司普通股之預定收購對價匯入受委任機構名下之公開收購專戶","clause":"第38款","fact_date":"2025-09-16","cite_as":"公開資訊觀測站重大訊息：健喬（4114），2025-09-16 14:38，「公告本公司已將本次公開收購健亞生物科技股份有限公司普通股之預定收購對價匯入受委任機構名下之公開收購專戶」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4114-2025-09-16-1438-193k8ar","company_id":"4114","company":"健喬","market":"上櫃","industry":"生技醫療","date":"2025-09-16","time":"14:38:12","subject":"公告本公司公開收購健亞生物科技(股)公司之普通股股份、","clause":"第38款","fact_date":"2025-09-16","cite_as":"公開資訊觀測站重大訊息：健喬（4114），2025-09-16 14:38，「公告本公司公開收購健亞生物科技(股)公司之普通股股份、」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6492-2025-09-16-1341-1dydg5g","company_id":"6492","company":"生華科","market":"上櫃","industry":"生技醫療","date":"2025-09-16","time":"13:41:42","subject":"生華科CX-5461NCI-NExTT計畫推進第三項臨床試驗，向FDA提出IND申請，將與賽諾菲/再生元製藥開發之已上市PD-1抑制劑Cemiplimab合併使用，治療難治性微衛星穩定型結直腸癌。","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：生華科（6492），2025-09-16 13:41，「生華科CX-5461NCI-NExTT計畫推進第三項臨床試驗，向FDA提出IND申請，將與賽諾菲/再生元製藥開發之已上市」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6934-2025-09-16-1021-k06w78","company_id":"6934","company":"心誠鎂","market":"上市","industry":"生技醫療","date":"2025-09-16","time":"10:21:00","subject":"更正本公司112年度合併及個體財務報告會計主管，財報更正並未有影響本公司損益金額之情事","clause":"第44款","fact_date":"2025-09-16","cite_as":"公開資訊觀測站重大訊息：心誠鎂（6934），2025-09-16 10:21，「更正本公司112年度合併及個體財務報告會計主管，財報更正並未有影響本公司損益金額之情事」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}